α 4 β 7 /α 4 β 1 Dual Integrin Antagonists Block α 4 β 7 -Dependent Adhesion under Shear Flow
The Journal of Pharmacology and Experimental Therapeutics, ISSN: 0022-3565, Vol: 302, Issue: 1, Page: 153-162
2002
- 10Citations
- 13Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes10
- 10
- CrossRef9
- Captures13
- Readers13
Article Description
The α 4 integrin, α 4 β 7, plays an important role in recruiting circulating lymphocytes to the gastrointestinal tract, where its ligand mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is preferentially expressed on high endothelial venules (HEVs). Dual antagonists of α 4 β 1 and α 4 β 7, N -(2,6-dichlorobenzoyl)-( l )-4-(2′,6′-bis-methoxyphenyl)phenylalanine (TR14035) and N -{ N -[(3,5-dichlorobenzene)sulfonyl]-2-( R )-methylpropyl}-( d )-phenylalanine (compound 1), were tested for their ability to block the binding of α 4 β 7 -expressing cells to soluble ligand in suspension and under in vitro and in vivo shear flow. Compound 1 and TR14035 blocked the binding of human α 4 β 7 to an 125 I-MAdCAM-Ig fusion protein with IC 50 values of 2.93 and 0.75 nM, respectively. Both compounds inhibited binding of soluble ligands to α 4 β 1 or α 4 β 7 on cells of human or rodent origin with similar potency. Under shear flow in vitro, TR14035 and compound 1 blocked binding of human α 4 β 7 -expressing RPMI-8866 cells or murine mesenteric lymph node lymphocytes to MAdCAM-Ig with IC 50 values of 0.1 and 1 μM, respectively. Intravital microscopy was used to quantitate α 4 -dependent adhesion of fluorescent murine lymphocytes in Peyer’s patch HEVs. When cells were prestimulated with 2 mM Mn 2+ to activate α 4 β 7 binding to ligand, anti-α 4 monoclonal antibody (mAb) [10 mg/kg (mpk) i.v.] blocked adhesion by 95%, and anti-β 1 mAb did not block adhesion, demonstrating that this interaction was dependent on α 4 β 7. TR14035 blocked adhesion to HEVs [ED 50 of 0.01–0.1 mpk i.v.], and compound 1 blocked adhesion by 47% at 10 mpk i.v. Thus, α 4 β 7 /α 4 β 1 antagonists blocked α 4 β 7 -dependent adhesion of lymphocytes to HEVs under both in vitro and in vivo shear flow.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022356524357465; http://dx.doi.org/10.1124/jpet.302.1.153; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0036088732&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12065712; https://linkinghub.elsevier.com/retrieve/pii/S0022356524357465; https://dx.doi.org/10.1124/jpet.302.1.153; https://jpet.aspetjournals.org/content/302/1/153
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know